KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition. (2019)
Attributed to:
Gene therapy for refractory epilepsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-08933-4
PubMed Identifier: 30874549
Publication URI: http://europepmc.org/abstract/MED/30874549
Type: Journal Article/Review
Volume: 10
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723